Cornel Jeansonne
Pediatrics · Slidell, LANPI 1477572543
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 36.5% of the total. Reporting peaked in 2022 at $542 and has fallen 51.9% since, to $261 in 2025. Among pediatrics clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$810
- Ironshore Pharmaceuticals Inc.$342
- Corium, LLC$254
- Pfizer$168
- Takeda Pharmaceuticals U.S.A., Inc.$114
- Merck$101
- plus $431 from 13 others
What the payments were for
- Consulting fees$251%
- Food & beverage$2,19499%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 41 | $810 |
| Ironshore Pharmaceuticals Inc. | 16 | $342 |
| Corium, LLC | 13 | $254 |
| Pfizer | 10 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $114 |
| Merck | 7 | $101 |
| Adlon Therapeutics L.p. | 6 | $78 |
| Sanofi Pasteur Inc. | 3 | $59 |
| Collegium Pharmaceutical, Inc. | 2 | $49 |
| Phadia US Inc. | 3 | $44 |
| Tris Pharma Inc | 2 | $42 |
| Cranial Technologies, Inc | 2 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Sarepta Therapeutics, Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
| Organon | 1 | $16 |
| Seqirus USA Inc | 1 | $14 |
| Qiagen, LLC | 1 | $14 |
How this compares
$2,219 in reported general payments places this provider in the 90th percentile of 913 pediatrics providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 12 | $135 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Slidell
- Corey HebertGretna$1.3M
- Katie QueenBogalusa$61K
- Elizabeth WhiteCovington$19K
- Neslihan GungorShreveport$16K
- Amy VitteLafayette$10K
- Alicia NicklasLafayette$9K
- Paul YuratichNew Orleans$9K
- Catherine SpillerWalker$8K
- Mamatha MandavaShreveport$8K
- Caroline KlineBaton Rouge$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.